Manchester Institute of Biotechnology, University of Manchester The Manchester Institute of Biotechnology (MIB) is the home of our research. We are located in state-of-the-art research labs on the 3rd floor of the building.
Centre for Synthetic Biology of Fine and Speciality Chemicals at MIB SYNBIOCHEM is actively engaged in challenging research projects that enable us to make significant advances in science to benefit industry and society. A portfolio is currently maintained that is already providing synbio solutions to the green manufacture of fine chemicals, therapeutic small molecules and new routes to biofuels.
The group is also involved in coordinating the MAGIC doctoral training award which aims to train the future generation of leading investigators in biological catalysis and enzymology and develop new enabling technologies that can advance physical understanding of catalysis and mechanism
We belong to the School of Chemistry at Manchester which is one of the largest in the UK and is recognised globally for the excellence of its research and teaching. It is part of the Faculty of Science and Engineering
We have programmed access to the world class research facilities at the Central Laser Facility at the Harwell Research Complex. We are also members of the Dynamic Structural Science Consortium (see academic links) at the same location.
The BBSRC are the main funders of our post-doctoral and post-graduate research programmes.
Nigel is an EPSRC Established Career Fellow.
Bruker sponsor our NMR and EPR studies on enzyme mechanism.
GSK sponsor projects in the areas of synthetic biology and biocatalysis.
Chirotech are a sponsor of our research in biocatalysis.
We work closely with TgK Scientific in instrument development and they sponsor research in enzyme catalysis.
Applied Photophysiscs are sponsoring research in our group on enzyme mechanism.
The EMF BRT sponsor our studies into the effect of magnetic fields on redox enzymes and cryptochrome.
The Colt Foundation are sponsoring our studies into the effect of magnetic fields on cryptochrome.
We are partners on this EU FP7 project to develop photobiological systems for the production of volatile hydrocarbon fuels.
We collaborate with Samar on a number of different redox enzymes.
We collaborate with Roberto in understanding the mechanism of oxygenase chemistry in the absence of any cofactor.
We collaborate with Mike on understanding the mechanism of gas binding to haem proteins.
We collaborate with Martin on using time-resolved SAXS and WAXS to study protein dynamics.
We collaborate with Bettie Sue on our studies on cytochrome P450 reductase (CPR).
We collaborate with Flav on our research on the inhibition of kynurenine monooxygenase (KMO) as a therapeutic target for the treatment of neurodegenative disorders, such as Huntington's disease and Alzheimer's.